These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Protective effects of a novel nonglucocorticoid 21-aminosteroid (U74006F) during traumatic shock in rats. Aoki N; Lefer AM J Cardiovasc Pharmacol; 1990 Feb; 15(2):205-10. PubMed ID: 1689414 [TBL] [Abstract][Full Text] [Related]
8. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock. Levitt MA; Lefer AM Prostaglandins Leukot Med; 1986 Dec; 25(2-3):175-85. PubMed ID: 2434958 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of PGE1 in hemorrhagic shock in rats. Bitterman H; Stahl GL; Terashita Z; Lefer AM Ann Emerg Med; 1988 May; 17(5):457-62. PubMed ID: 3364825 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of two leukotriene antagonists in rat traumatic shock. Levitt MA; Lefer AM Methods Find Exp Clin Pharmacol; 1987 May; 9(5):269-73. PubMed ID: 3613754 [TBL] [Abstract][Full Text] [Related]
11. Protective actions of nafazatrom in traumatic shock. Lefer AM; Messenger M Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock. Stahl GL; Bitterman H; Lefer AM Thromb Res; 1989 Feb; 53(3):327-38. PubMed ID: 2718150 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock. Hock CE; Lefer AM Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock. Bitterman H; Stahl GL; Lefer AM Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456 [TBL] [Abstract][Full Text] [Related]
15. Role of the splanchnic visceral organs in development of tolerance to traumatic shock. Araki H; Sollott SJ; Lefer AM J Trauma; 1980 Dec; 20(12):1046-51. PubMed ID: 7452749 [TBL] [Abstract][Full Text] [Related]
16. Protective effects of a novel thromboxane analog in lethal traumatic shock. Lefer AM; Araki H; Smith JB; Nicolaou KC; Magolda RL Prostaglandins Med; 1979 Sep; 3(3):139-46. PubMed ID: 552102 [TBL] [Abstract][Full Text] [Related]
17. Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed. Hyman AL; Kadowitz PJ J Pharmacol Exp Ther; 1980 Jun; 213(3):468-72. PubMed ID: 7193724 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of KW-3635, a novel thromboxane A2 antagonist, in murine traumatic shock. Karasawa A; Taylor PA; Lefer AM Eur J Pharmacol; 1990 Jun; 182(1):1-8. PubMed ID: 2401310 [TBL] [Abstract][Full Text] [Related]
19. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock. Aoki N; Johnson G; Siegfried MR; Lefer AM Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278 [TBL] [Abstract][Full Text] [Related]
20. Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects. Jackson EK; Goodman RP; Fitzgerald GA; Oates JA; Branch RA J Pharmacol Exp Ther; 1982 Apr; 221(1):183-7. PubMed ID: 7038095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]